Fig. 7From: Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survivalHER2 immunostain in studied MIBC cases. A: UC case showing + 3 HER2 positivity (× 400). B: Another UC case with + 2 HER2 (× 400)Back to article page